Laparoscopic sleeve gastrectomy combined with montelukast for obese patients with secretory otitis media
World Journal of Gastrointestinal Surgery · 27.06.2026 · 18 (6)
DOI: 10.4240/wjgs.120692 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Surgery, online erschienen am 27.06.2026. Verfasst von Hua-Long Qiang und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Obesity is associated with increased risk of otitis media with effusion (OME), potentially due to peritubal fat accumulation and chronic inflammation. Laparoscopic sleeve gastrectomy (LSG) effectively reduces weight but achieves slow early middle ear effusion resolution. Montelukast, a leukotriene receptor antagonist, possesses anti-inflammatory properties that may promote OME recovery. However, rapid weight loss may paradoxically induce patulous eustachian tube, complicating outcome interpretation. We hypothesized that combining LSG with montelukast would accelerate middle ear effusion clearance and improve eustachian tube function without compromising weight loss efficacy. AIM To evaluate LSG combined with montelukast for obese patients with OME regarding recovery, eustachian tube function, and weight loss. METHODS This retrospective cohort study enrolled 112 obese OME patients treated at a tertiary hospital between January 2020 and March 2025. Groups: Control (n = 48, LSG alone) and observation (n = 64, LSG plus oral montelukast 10 mg/day for one month). Outcomes included total weight loss, excess weight loss, middle ear effusion resolution time, air-bone gap, Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) score, 36-Item Short Form Health Survey (SF-36), and adverse events. Assessors were blinded. Inter-group comparisons used t tests and χ 2 tests. RESULTS Baseline characteristics were comparable between groups (P > 0.05). Weight loss outcomes at 1 months and 6 months showed no significant inter-group differences (P > 0.05). Middle ear effusion clearance was significantly faster in the observation group compared to controls (28.39 ± 6.51 days vs 42.10 ± 8.32 days, P < 0.001). At one month postoperatively, the observation group demonstrated superior air-bone gap reduction (18.92 ± 4.65 dB vs 22.04 ± 4.57 dB, P = 0.001) and lower ETDQ-7 scores (2.63 ± 0.97 vs 3.75 ± 1.16, P < 0.001). SF-36 scores favored the observation group at 1 month and 3 months (P < 0.01). Adverse event rates were comparable between groups (7.81% vs 4.17%, P > 0.05). CONCLUSION LSG combined with montelukast significantly accelerates middle ear effusion resolution, improves auditory function and quality of life in obese OME patients, with maintained weight loss and favorable short-term safety.
Zitieren
APA
Qiang, H., Yao, X., Jiang, Z., & Wang, W. (2026). Laparoscopic sleeve gastrectomy combined with montelukast for obese patients with secretory otitis media. World Journal of Gastrointestinal Surgery, 18(6). https://doi.org/10.4240/wjgs.120692
Vancouver
Qiang H, Yao X, Jiang Z, Wang W. Laparoscopic sleeve gastrectomy combined with montelukast for obese patients with secretory otitis media. World Journal of Gastrointestinal Surgery. 2026;18(6). doi:10.4240/wjgs.120692
BibTeX
@article{Qiang2026,
author = {Qiang, Hua-Long and Yao, Xiang-Li and Jiang, Zhen-Feng and Wang, Wei},
title = {Laparoscopic sleeve gastrectomy combined with montelukast for obese patients with secretory otitis media},
journal = {World Journal of Gastrointestinal Surgery},
year = {2026},
volume = {18},
number = {6},
doi = {10.4240/wjgs.120692}
}
EUVIMED